Published on GHDx (https://ghdx.healthdata.org)

Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset

General Info

Geography 
Portugal (PRT)
Time period covered 
January, 2020 - December, 2020
Data type
Scientific literature
Keywords 
COVID-19

Citation

Authors 
Figueiredo-Campos P, Blankenhaus B, Mota C, Gomes A, Serrano M, Ariotti S, Costa C, Nunes-Cabaço H, Mendes AM, Gaspar P, Pereira-Santos MC, Rodrigues F, Condeço J, Escoval MA, Santos M, Ramirez M, Melo-Cristino J, Simas JP, Vasconcelos E, Afonso Â, Veldhoen M
Journal 
Eur J Immunol
Pages 
2025-2040
Publication year 
2020
Suggested citation 
Figueiredo-Campos P, Blankenhaus B, Mota C, Gomes A, Serrano M, Ariotti S, Costa C, Nunes-Cabaço H, Mendes AM, Gaspar P, Pereira-Santos MC, Rodrigues F, Condeço J, Escoval MA, Santos M, Ramirez M, Melo-Cristino J, Simas JP, Vasconcelos E, Afonso Â, Veldhoen M. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset. Eur J Immunol. 2020; 50(12): 2025-2040.
Source URL:https://ghdx.healthdata.org/record/seroprevalence-anti-sars-cov-2-antibodies-covid-19-patients-and-healthy-volunteers-6-months#comment-0